Br J Pharmacol 1997
Since GSH cannot be administered clinically, a variety of precursors or chemically modified analogues have been generated to mimic pharmacologic effects of GSH
4 , 116122 (2008) Bussi, G., Donadio, D
-sitosterol targets ASS1 for Nrf2 ubiquitin-dependent degradation, inducing ROS-mediated apoptosis via the PTEN/PI3K/AKT signaling pathway in ovarian cancer
[DOI] [PMC free article] [PubMed] [Google Scholar] 35.Dragonieri S., Portacci A., Quaranta V.N., Carratu P., Lazar Z., Carpagnano G.E., Bikov A
Start low, go slow Beginner approach: Start with single peptide (BPC-157 recommended) Use minimum effective dose Run for 4-8 weeks before adding anything Assess tolerance and results Dose escalation: Begin at lowest recommended dose Increase by 25% every 2-3 weeks if needed Stop increasing when seeing good results More isn't always better Adding peptides: Add one new peptide at a time Wait 2-4 weeks between additions This identifies which peptide causes any issues Proper injection technique Critical for safety: Always use sterile technique Clean injection sites with alcohol Rotate injection sites (prevent tissue damage) Use appropriate needle size (insulin syringes for subcutaneous) Never share needles Infection prevention: New sterile needle every injection Wash hands thoroughly Wipe vial top before drawing Don't touch needle to anything See our complete peptide injections guide for detailed technique
